The new generic products which were recently developed.,The marketed original products which were already available in the market.

A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Pregabalin Capsules 50 mg relative to Brillior® 50 mg in healthy Thai volunteers under fasting condition

Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Montelukast Granules (4 mg) relative to Singulair(R) (Original Montelukast Granules (4 mg)) in healthy Thai volunteers under fasting condition